Pacira | PCRX - Ebit


Pacira reported $2.57B in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
Astellas Pharma JPY 132.59B 52.76B Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Cara Therapeutics USD -7.05M 1.11M Mar/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 6.47B 1B Sep/2026
Ligand Pharmaceuticals USD 54.53M 2.1M Sep/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novo Nordisk DKK 33.76B 25.86B Jun/2026
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 2.57B 2.56B Sep/2026
Perrigo USD 27.2M 116.6M Sep/2026
Pfizer USD 4.85B 5.03B Sep/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
Xeris Pharmaceuticals USD -24.15M 33.27M Jun/2026
Zoetis USD 1.03B 88M Sep/2026